KAZALD1

KAZALD1
Identifiers
Aliases	KAZALD1, BONO1, FKSG28, FKSG40, IGFBP-rP10, Kazal type serine peptidase inhibitor domain 1
External IDs	MGI: 2147606 HomoloGene: 12799 GeneCards: KAZALD1
Gene ontology Molecular function • insulin-like growth factor binding Cellular component • proteinaceous extracellular matrix • extracellular region • interstitial matrix Biological process • multicellular organism development • cell differentiation • extracellular matrix organization • regulation of cell growth • ossification Sources:Amigo / QuickGO
RNA expression pattern
More reference expression data
Orthologs
Species	Human	Mouse
Entrez	81621	107250
Ensembl	ENSG00000107821	ENSMUSG00000025213
UniProt	Q96I82	Q8BJ66
RefSeq (mRNA)	NM_030929 NM_001319303	NM_178929
RefSeq (protein)	NP_112191.2 NP_001306232.1	NP_849260.2
Location (UCSC)	Chr 10: 101.06 – 101.07 Mb	Chr 19: 45.08 – 45.08 Mb
PubMed search	[1]	[2]
Wikidata

View/Edit Human

View/Edit Mouse

Kazal-type serine protease inhibitor domain-containing protein 1 is an enzyme that in humans is encoded by the KAZALD1 gene.^[3][4]

References

1. "Human PubMed Reference:".
2. "Mouse PubMed Reference:".
3. Clark HF, Gurney AL, Abaya E, Baker K, Baldwin D, Brush J, Chen J, Chow B, Chui C, Crowley C, Currell B, Deuel B, Dowd P, Eaton D, Foster J, Grimaldi C, Gu Q, Hass PE, Heldens S, Huang A, Kim HS, Klimowski L, Jin Y, Johnson S, Lee J, Lewis L, Liao D, Mark M, Robbie E, Sanchez C, Schoenfeld J, Seshagiri S, Simmons L, Singh J, Smith V, Stinson J, Vagts A, Vandlen R, Watanabe C, Wieand D, Woods K, Xie MH, Yansura D, Yi S, Yu G, Yuan J, Zhang M, Zhang Z, Goddard A, Wood WI, Godowski P, Gray A (Oct 2003). "The Secreted Protein Discovery Initiative (SPDI), a Large-Scale Effort to Identify Novel Human Secreted and Transmembrane Proteins: A Bioinformatics Assessment". Genome Res. 13 (10): 2265–70. doi:10.1101/gr.1293003. PMC 403697. PMID 12975309.
4. "Entrez Gene: KAZALD1 Kazal-type serine peptidase inhibitor domain 1".

Further reading

• Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
• Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
• Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
• Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
• Deloukas P, Earthrowl ME, Grafham DV, et al. (2004). "The DNA sequence and comparative analysis of human chromosome 10". Nature. 429 (6990): 375–81. doi:10.1038/nature02462. PMID 15164054.
• James MJ, Järvinen E, Thesleff I (2005). "Bono1: a gene associated with regions of deposition of bone and dentine". Gene Expr. Patterns. 4 (5): 595–9. doi:10.1016/j.modgep.2004.01.013. PMID 15261838.
• Zhang Z, Henzel WJ (2005). "Signal peptide prediction based on analysis of experimentally verified cleavage sites". Protein Sci. 13 (10): 2819–24. doi:10.1110/ps.04682504. PMC 2286551. PMID 15340161.
• Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
• Shibata Y, Tsukazaki T, Hirata K, et al. (2005). "Role of a new member of IGFBP superfamily, IGFBP-rP10, in proliferation and differentiation of osteoblastic cells". Biochem. Biophys. Res. Commun. 325 (4): 1194–200. doi:10.1016/j.bbrc.2004.10.157. PMID 15555553.